How We Treat Drug-Susceptible Pulmonary Tuberculosis: A Practical Guide for Clinicians-Reference-Cited by-同舟云学术

How We Treat Drug-Susceptible Pulmonary Tuberculosis: A Practical Guide for Clinicians

Published:2023-12-14 Issue:12 Volume:12 Page:1733
ISSN:2079-6382
Container-title:Antibiotics
language:en
Short-container-title:Antibiotics

Author:

Riccardi Niccolò¹²,Occhineri Sara¹²^ORCID,Vanino Elisa¹³^ORCID,Antonello Roberta Maria¹^ORCID,Pontarelli Agostina¹⁴,Saluzzo Francesca¹⁵,Masini Tiziana¹,Besozzi Giorgio¹^ORCID,Tadolini Marina¹⁶⁷,Codecasa Luigi¹⁸^ORCID,

Affiliation:

1. StopTB Italia ODV, 20159 Milan, Italy

2. Infectious Diseases Unit, Azienda Ospedaliera Universitaria Pisana, 56124 Pisa, Italy

3. Infectious Diseases Unit, Santa Maria delle Croci Hospital, AUSL Romagna, 48100 Ravenna, Italy

4. Unit of Respiratory Infectious Diseases, Cotugno Hospital, Azienda Ospedaliera dei Colli, 80131 Naples, Italy

5. Emerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Vita-Salute, San Raffaele University, 20132 Milan, Italy

6. Infectious Disease Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy

7. Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, 40138 Bologna, Italy

8. Regional TB Reference Centre, Villa Marelli Institute, ASST Grande Ospedale Metropolitano Niguarda, 20159 Milan, Italy

Abstract

Tuberculosis (TB) remains one of the leading causes of morbidity and mortality worldwide and pulmonary TB (PTB) is the main variant responsible for fueling transmission of the infection. Effective treatment of drug-susceptible (DS) TB is crucial to avoid the emergence of Mycobacterium tuberculosis-resistant strains. In this narrative review, through a fictional suggestive case of DS PTB, we guide the reader in a step-by-step commentary to provide an updated review of current evidence in the management of TB, from diagnosis to post-treatment follow-up. World Health Organization and Centre for Diseases Control (CDC) guidelines for TB, as well as the updated literature, were used to support this manuscript.

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Pharmacology, Toxicology and Pharmaceutics,Biochemistry,Microbiology

Link

https://www.mdpi.com/2079-6382/12/12/1733/pdf

Reference122 articles.

1. WHO (2021). WHO Consolidated Guidelines on Tuberculosis. Module 2: Screening—Systematic Screening for Tuberculosis Disease, WHO. Licence: CC BY-NC-SA 3.0 IGO.

2. WHO (2023). Global Tuberculosis Report 2023, World Health Organization. Licence: CC BY-NC-SA 3.0 IGO.

3. The evolution of a neglected disease: Tuberculosis discoveries in the centuries;Riccardi;J. Prev. Med. Hyg.,2020

4. The social determinants of health: Key to global tuberculosis control;Rasanathan;Int. J. Tuberc. Lung Dis.,2011

5. Holmes, K.K., Bertozzi, S., Bloom, B.R., and Jha, P. (2017). Tuberculosis. Major Infectious Diseases, The International Bank for Reconstruction and Development/The World Bank. [3rd ed.].

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Features of Pulmonary Tuberculosis (TB): Linking Biomarkers and Quality of Life Measures;Handbook of the Behavior and Psychology of Disease;2024